# DRA-PUB-003A — Scientific and Statistical Manuscript Audit Report

**Scope:** an editorial/scientific correction pass over `docs/dra/DRA-PUB-003-MANUSCRIPT.md` only. No evaluator, corpus, governance, GC-1, GEN-001, ENG-026, GC2-REV-001, VAL-002, proof-receipt, or other evidence-bearing artefact was read for the purpose of modification, and none was modified. Repository evidence is treated throughout as the sole authority for every correction.

Each of the ten mandatory issues below is reported with: the original wording/data, the evidence consulted, the verdict, and the correction made (or the reasoning for no correction).

---

## Issue 1 — GEN-001 rule-of-three math error

- **Original wording:** "Operational-reliability endpoints … were all 75/75 (100%, rule-of-three upper bound on failure ≤3.0% at 95% confidence)" (body, Section 8) and the identical figure in Table 3.
- **Evidence:** `docs/dra/DRA-GEN-001-POST-BLIND-EVIDENCE-REVIEW.md` and `DRA-GEN-001-PHASE-2-BLIND-EXECUTION-REPORT.md` both state "rule-of-three upper bound ≤0.030 at n=75" for the three n=75 rates (pipeline completion, proof integrity, determinism), and separately "≤0.030 at n=100" for the n=100 material-failure rate.
- **Verdict:** confirmed mathematical error, present in the manuscript **and traced to the same error already existing in the underlying GEN-001 evidence reports**. The standard rule-of-three approximation for zero events is 3/n: at n=75 this is 3/75 = 0.04 (4.0%), not 0.03 (3.0%). The 3.0% figure is only correct for n=100 (3/100 = 0.03); it appears to have been carried over unchanged to the n=75 quantities in the source reports without recalculation. Separately, the reports' own correctly-computed Wilson score interval for 0/75 is `[0.951, 1.000]` (verified by direct recomputation: centre 0.9756 ± margin 0.0244), i.e. an upper failure bound of ≈4.9%, which is consistent with (and stronger evidence than) the corrected 4.0% rule-of-three approximation, and not with the erroneous 3.0% figure.
- **Correction made (manuscript only):** replaced "(100%, rule-of-three upper bound on failure ≤3.0% at 95% confidence)" with "(100%, Wilson 95% CI [95.1%, 100%]; rule-of-three approximation ≤4.0% at n=75)" in both the Section 8 body text and Table 3. The n=100 material-failure figure (0/100, rule-of-three ≤3.0%) and the n=25 VAL-002 figure (0/25, rule-of-three ≤12%) were independently re-verified as arithmetically correct (3/100 = 3.0%; 3/25 = 12.0%) and were left unchanged.
- **Escalation (not corrected, per scope):** the underlying GEN-001 evidence reports (`DRA-GEN-001-POST-BLIND-EVIDENCE-REVIEW.md`, `DRA-GEN-001-PHASE-2-BLIND-EXECUTION-REPORT.md`) contain the same ≤0.030-at-n=75 error in at least 4 locations. These are evidence-bearing artefacts and are explicitly out of scope for this audit's correction authority; a human maintainer should decide whether to issue a dedicated correction to those reports.

## Issue 2 — VAL-002 "majority" overstatement

- **Original wording:** "a re-fetch-verification design, as GEN-001 used, would again have discarded a majority of this sample."
- **Evidence:** `DRA-VAL-002-ENGLISH-HTML-BLIND-VALIDATION-REPORT.md` §7 and the manuscript's own Table 4: of 25 post-hoc-observed URLs, 15 were byte-identical, 7 had drifted, 3 were unreachable. Drifted + unreachable = 10/25 = 40%.
- **Verdict:** confirmed overstatement. 40% is a substantial fraction, not a majority (>50%).
- **Correction made:** replaced with "would again have discarded a substantial fraction of this sample (10 of 25, 40%)" in Section 10's body text.

## Issue 3 — Language/script terminology inflation

- **Original wording:** "five language families across Latin, CJK ideographic, and Cyrillic scripts" (Section 5); "Languages / scripts | English, Spanish, French (Latin script); Japanese (CJK ideographic); Bulgarian (Cyrillic)" (Table 1); "Non-Latin script coverage limited to CJK + Cyrillic" (Table 6); "only Japanese (CJK) and Bulgarian (Cyrillic) have ever tested non-Latin script handling" (Section 14); "non-Latin script coverage beyond CJK and Cyrillic" (Section 10).
- **Evidence:** the corpus contains English, Spanish, French, Japanese, and Bulgarian documents — five languages, not five language families (a language family is a genealogical grouping, e.g. Indo-European; these five languages belong to at most three families and the manuscript was not making a genealogical claim). "CJK" (Chinese/Japanese/Korean) is a conventional grouping of countries/character-set traditions, not a script name, and only Japanese was tested — no Chinese or Korean document was ever admitted (confirmed via `DRA-ROB-002-GC1-FREEZE-READINESS-REVIEW.md` row 10: "Non-Latin scripts | PARTIALLY_TESTED (CJK only)" refers to the CJK-family test point being Japanese specifically). Japanese itself is not one script but a mixed logographic (kanji) and syllabic (hiragana, katakana) writing system.
- **Verdict:** confirmed terminology inflation on both counts.
- **Correction made:** replaced all five instances above with language- and script-precise wording, e.g. "five languages spanning three writing systems: Latin script (English, Spanish, French), the Japanese writing system (a mixed logographic/syllabic system combining kanji, hiragana, and katakana), and Cyrillic script (Bulgarian)"; "Non-Latin script coverage limited to Japanese + Cyrillic"; "only Japanese (its own mixed logographic/syllabic writing system) and Bulgarian (Cyrillic script) … no Devanagari, Arabic, Hebrew, Hangul, or Chinese/Korean document has ever been admitted or evaluated" (the explicit addition of "Chinese/Korean" here corrects the residual risk that a reader could otherwise infer CJK-wide coverage); "non-Latin script coverage beyond the Japanese and Cyrillic scripts tested."

## Issue 4 — "Independently reproduced" wording

- **Original wording:** "the study independently reproduced the same 3-of-9 issue-class reachability finding described in Section 4" (Section 8); "confirmed independently inside GEN-001's blind sample" (Table 5, reachability row).
- **Evidence:** `DRA-PUBLIC-CLAIMS.md` global rule 1: "independently validated" must never be used for GEN-001, VAL-002, or the programme as a whole, since no third party has participated. The reachability re-observation inside GEN-001 was performed by the same evaluator, same programme, same team — it is a within-programme replication on a second (blind) dataset, not an organisationally independent confirmation.
- **Verdict:** confirmed risk of misreading "independently" as organisational independence in these two specific instances.
- **Correction made:** Section 8 changed to "the same 3-of-9 issue-class reachability finding described in Section 4 was reproduced within this blind-study sample"; Table 5 changed to "reconfirmed inside GEN-001's blind sample." Other uses of "independent(ly)" in the manuscript were individually reviewed and left unchanged because they refer to a different, legitimate sense of independence explicitly permitted by the repository's own conventions — cryptographic/digest independent re-verification (e.g. "independently re-hashable," "independently re-checkable," "independently recomputed"), or a fresh, separately-executed computational re-derivation (DRA-GC2-REV-001 "independently reproduced ENG-026's own evidence" via a live re-run, not by trusting stored results) — none of which claims third-party/organisational independence, and Sections 8 and 10 each already carry an explicit, adjacent disclaimer that GEN-001/VAL-002 are not external or third-party validation.

## Issue 5 — Section 15 central claim overclaim check

- **Original wording:** "a deterministic, reproducible evaluator can be built that meaningfully distinguishes documents with adequate, self-consistent evidentiary support from those without it, at least for the three issue classes it currently reaches, and that this capability survives contact with a genuinely blind, pre-registered evaluation exercise."
- **Evidence:** `DRA-PUBLIC-CLAIMS.md` "What problem DRA addresses" requires the scope boundary (languages/formats/domains) to be stated "in the same breath" as the problem statement, not merely elsewhere in the document.
- **Verdict:** the claim was already scoped to "the three issue classes it currently reaches" but omitted the equally load-bearing language/format/domain scope boundary from the same sentence, which is a partial overclaim by omission.
- **Correction made:** added the missing scope clause: "...at least for the three issue classes it currently reaches and within the disclosed scope of languages, formats, and domains this programme has tested, and that this capability survives contact with an internal, pre-registered, contamination-blind evaluation exercise..." (this edit also resolves Issue 6, see below).

## Issue 6 — "Genuinely blind" wording

- **Original wording:** "...survives contact with a genuinely blind, pre-registered evaluation exercise..." (Section 15).
- **Evidence:** `DRA-PUBLIC-CLAIMS.md` global rule 2 and the canonical DRA-GEN-001/DRA-VAL-002 entries both use the fixed phrase "internal, pre-registered, contamination-blind" throughout; "genuinely blind" does not appear in the canonical register and, as a stand-alone intensifier, risks reading as a stronger/different assurance than the precisely defined term.
- **Verdict:** confirmed deviation from established canonical terminology.
- **Correction made:** replaced "a genuinely blind, pre-registered evaluation exercise" with "an internal, pre-registered, contamination-blind evaluation exercise" (same edit as Issue 5).

## Issue 7 — Robustness defect count reconciliation

- **Original wording:** Section 6 body text already lists exactly five items ("a quadratic-time scalability defect in Stage 4…; two citation-linkage extraction defects…; a three-part legal-authority/document-currentness chain…; Unicode segmentation…; and a lowercase-follows-period sentence-boundary false positive") — this is a five-item list correctly grouping the two citation defects under one bullet and the three-part authority/currentness chain under another. Table 5, however, cited only four engineering-report groupings for "5 defects engineered and closed": "ENG-016, ENG-019, ENG-020/021/022, ENG-023."
- **Evidence:** `DRA-ROB-002-GC1-FREEZE-READINESS-REVIEW.md`'s 18-dimension robustness matrix classifies exactly five dimensions `DEFECT_DEMONSTRATED_AND_CLOSED` / `CLOSED_STRONGLY_EVIDENCED`: #4 (very large documents/scalability), #5 (scientific citations/references), #6 (legal authority/versioning), #7 (document supersession/currentness), and #18 (bare-EN/EL-STANDARD-REF false positive). `DRA-PUB-001-FINAL-EVIDENCE-SYNTHESIS.md` independently establishes the same five-item grouping and count, explicitly naming the fifth item as "the lowercase-bare-'EN' sentence-boundary false positive (ENG-012/013/014/014A)" — confirming this is the same defect as ROB-002's dimension #18, referred to by a compound name.
- **Verdict:** the Section 6 prose count of five was already correct and consistent with `DRA-ROB-002` and `DRA-PUB-001` precedent. The defect **was** miscounted nowhere in the prose; the error was a citation-completeness gap in Table 5, which named only 4 of the 5 underlying engineering closure reports (omitting ENG-012/013/014/014A, the report chain that closed the fifth listed defect).
- **Correction made:** Table 5's "5 defects engineered and closed" row expanded to name all five items and their closure reports explicitly: "ENG-016 (citation/reference-linkage), ENG-019 (Stage 4 scalability), ENG-020/021/022 (legal-authority/currentness/supersession chain), ENG-023 (Unicode segmentation), ENG-012/013/014/014A (bare-"EN"/EL-STANDARD-REF sentence-boundary false positive) closure reports." No change was needed to Section 6's prose list or its count of five, both of which were already correct.

## Issue 8 — Full statistical audit of all six tables

Every numerator/denominator/percentage/CI pairing in Tables 1–6 and the corresponding body-text sentences was independently recomputed:

| Statement | Recomputation | Result |
|---|---|---|
| GEN-001 operational-reliability rate, 75/75, rule-of-three | 3/75 | **Error found — see Issue 1** |
| GEN-001 operational-reliability rate, 75/75, Wilson CI | Wilson score interval, x=75, n=75, z=1.96 → centre 0.9756, margin 0.0244 | **[0.951, 1.000] confirmed correct** (now cited in place of the erroneous rule-of-three figure) |
| GEN-001 acquisition success, 75/100 = 75.0%, Wilson CI [65.7%, 82.5%] | Wilson score interval, x=75, n=100 → centre 0.7410, margin 0.0838 | Confirmed correct |
| GEN-001 material-failure rate, 0/100, Wilson CI [0%, 3.7%] | Wilson score interval, x=0, n=100 | Confirmed correct (matches source report's own 0.037 figure) |
| GEN-001 material-failure rate, rule-of-three ≤3.0% at n=100 | 3/100 | Confirmed correct (this is the one n=100 rule-of-three figure the source reports state correctly) |
| VAL-002 primary endpoints, Wilson CI [86.7%, 100%] at n=25 | Wilson score interval, x=25, n=25 → centre 0.9334, margin 0.0666 | Confirmed correct |
| VAL-002 material-failure rate, rule-of-three ≤12% at n=25 | 3/25 | Confirmed correct |
| VAL-002 post-hoc drift, 15/25 + 7/25 + 3/25 = 25/25 | Sum check | Confirmed correct and exhaustive |
| VAL-002 "would discard a majority" | 10/25 = 40% | **Error found — see Issue 2** |
| "100 documents across two protocols" (Abstract, Section 10) | 75 (GEN-001) + 25 (VAL-002) = 100, each denominator shown separately throughout, never pooled into one rate | Confirmed compliant with the no-pooling requirement; each study's own rates and confidence intervals are always reported against their own denominator, and Section 10 explicitly states the "one legitimate combined statement" is the raw count, not a pooled statistic |
| Development corpus counts (33 admitted, 1 reserved-not-admitted) | Cross-checked against Table 1 and Section 5/14 | Confirmed correct and consistent |
| Descriptive-vs-inferential labelling | The Spanish/English 50/50 vs 11/25 pattern (Section 8) and the ENG-026 controlled 25/25 vs 11/25 matrix (Section 9) | Both are explicitly and correctly labelled "descriptive"/"exploratory signal, not a validated language effect" (Section 8) and "confirmed" only for the specific controlled experiment that established causal mechanism (Section 9) — no descriptive finding is mislabelled as an inferential conclusion |

No other arithmetic or statistical-method errors were found across the six tables.

## Issue 9 — Full scientific-claim audit against `DRA-PUBLIC-CLAIMS.md`

Every manuscript sentence touching reliability, adequacy, verification, validation, generalisation, blindness, independence, evidence/provenance/authority, machine consumption, trust infrastructure, and production applicability was checked against the corresponding canonical entry:

- **What DRA is / research-stage qualifier:** every reference to DRA states or implies "research-stage"; the rejected-titles section (Section "Rejected title candidates") explicitly documents rejecting "production," "validated," "universal," and "trust infrastructure" framings — consistent with the canonical entry.
- **Problem statement / scope:** Section 1–2 state the problem (evidentiary structure, not factual truth) without claiming to "solve unreliable documents" or "verify truth" — consistent.
- **3/9 reachability:** stated with the required "structurally unreachable ... by the current implementation" framing (Section 11, item 2) — consistent; corrected per Issue 4 to avoid overstating the reproduction as organisationally independent.
- **GC-1 framing:** "frozen" is consistently used to mean code/version immutability (Section 7), never "final" or "production-certified" — consistent.
- **GEN-001 / VAL-002:** both are consistently described as "internal, pre-registered, contamination-blind" (with the "genuinely blind" deviation corrected per Issue 6), and Sections 8 and 10 each carry an explicit "must never be described as external or third-party validation" disclaimer matching the canonical qualification — consistent.
- **Generalisation:** Section 10 and the Abstract both state the tested scope (English/Spanish, PDF/HTML, UK/US/EU public-sector) alongside every generalisation claim and never state generalisation unscoped — consistent.
- **Robustness:** Section 6 and Table 5 name the specific failure modes found/closed/disclosed and never claim "no undiscovered failure modes" or "fully robust" — consistent.
- **Determinism/reproducibility:** Section 13's Mode A/Mode B distinction matches the canonical qualification exactly (frozen-byte reproduction vs. live re-fetch, never "reproducible from the live web") — consistent.
- **Evidence/provenance/authority:** Section 14 states plainly that DRA "does not independently fact-check claims against external ground truth" — consistent with the canonical "DRA does not verify factual accuracy" prohibition.
- **Machine consumption:** Section 14 and the Authorship section both state this is untested/future-tense, matching the canonical "has not been tested or deployed" framing — consistent.
- **Trust infrastructure:** Section 15 explicitly frames this as prospective/interpretive ("it is not reasonable... that DRA has already become such infrastructure") and Section 14 states the same — consistent with the canonical requirement that the phrase never appear as an achieved fact.
- **Mandatory global rule 1 (no "independently validated"):** searched the full manuscript; the phrase does not appear anywhere, and every validation-adjacent sentence instead uses the required "internal" qualifier or explicitly states "No external or third-party validation has yet been performed" (Section 14) — consistent.

No additional overclaims beyond Issues 1–7 were found under this audit.

## Issue 10 — Authorship/AI-disclosure accuracy check

- **Original wording:** the "Authorship and AI-assistance disclosure" section (unchanged by this audit).
- **Evidence:** the section states a human principal directed the programme (research questions, scope/gating decisions, final responsibility), and that "the evaluator's implementation, the acquisition and freeze infrastructure, the blind-study protocols and execution code, and this manuscript's drafting were produced with substantial AI assistance," further itemising "AI-assisted research synthesis, code generation, test and report generation, and repository-grounded verification of every quantitative claim."
- **Verdict:** this already covers all required categories — implementation, research assistance (synthesis), code generation, test generation, report generation, manuscript drafting, and repository-grounded verification — states human responsibility and direction clearly, and explicitly disclaims any human contributor beyond the directing principal and any AI authorship credit. No gap, invented contributor, or minimisation was found.
- **Correction made:** none required.

---

## Verification performed

1. **Manual arithmetic re-verification** of every rule-of-three and Wilson-interval figure in the manuscript (shown in Issue 8's table), computed independently from the stated numerator/denominator using the standard formulas, not copied from the manuscript or the source reports.
2. **Cross-reference check** of the robustness-defect count and citations (Issue 7) against `DRA-ROB-002-GC1-FREEZE-READINESS-REVIEW.md`'s 18-dimension matrix and `DRA-PUB-001-FINAL-EVIDENCE-SYNTHESIS.md`'s own five-item grouping.
3. **Full-text claim-boundary audit** (Issue 9) of every sentence in the manuscript against `docs/dra/DRA-PUBLIC-CLAIMS.md`'s canonical wording and four mandatory global rules.
4. **Companion-document check:** grepped `DRA-PUB-003-REPORT.md`, `DRA-ATTRIBUTION.md`, `DRA-CITATION.cff`, and `DRA-RELEASE-README.md` for the same flawed figures/phrases found in the manuscript ("language famil[y/ies]", "CJK ideographic", "discarded a majority", the erroneous 3.0%/n=75 figure, and the incomplete Table-5 defect-citation string). None were found in any companion document, so no companion-document edits were required or made.
5. **Evidence-integrity re-run:** re-ran the GC-1/GEN-001/VAL-002/PUB-001/ROB-002 freeze-integrity and evidence-synthesis test suite (9 files, 218 tests) — all passing — plus 6 additional acquisition/closure suites touching VAL-002 and ENG-026/ENG-022 (4 files, 50 tests passing; 2 files, 2 tests failing). The 2 failures are pre-existing, unrelated residuals (a stale evaluator-version-literal assertion expecting `0.1.1` against the current frozen `0.1.2`, and a stale reference digest in an analytical-review test) — both confirmed via `git status`/`git diff --stat` to be untouched by this audit, since this audit's only modification to the entire repository is `docs/dra/DRA-PUB-003-MANUSCRIPT.md` itself. These failures therefore predate and are independent of this audit's edits.
6. **Confirmed via `git status --short`** that the only tracked-file change made in the course of this audit is `docs/dra/DRA-PUB-003-MANUSCRIPT.md`; no evaluator, corpus, governance, GC-1, GEN-001, ENG-026, GC2-REV-001, VAL-002, or proof-receipt file was touched.

## Word count after correction

**6,315 words** (`wc -w docs/dra/DRA-PUB-003-MANUSCRIPT.md`), up from 6,244 before this audit (+71 words, entirely from precision expansions: the Wilson-CI restatement, the explicit five-item Table 5 citation, the added scope clause in Section 15, and the explicit "Chinese/Korean" exclusion).

## Remaining issue requiring human judgement

The GEN-001 rule-of-three arithmetic error (Issue 1) is also present, unaddressed, in the underlying evidence reports (`DRA-GEN-001-POST-BLIND-EVIDENCE-REVIEW.md`, `DRA-GEN-001-PHASE-2-BLIND-EXECUTION-REPORT.md`). This audit's scope permitted correcting only the manuscript's citation of that figure, not the source reports themselves. A human maintainer should decide whether to issue a dedicated, narrowly-scoped correction to those two evidence documents (which would itself need to go through the same non-merge, evidence-integrity discipline used throughout this programme, since they are frozen-adjacent evidentiary records, not drafts).

---

## Final Remediation — Historical Statistical Erratum and Publication Manuscript Freeze

Following the initial audit (above), the one remaining open item — the rule-of-three arithmetic error preserved in the historical GEN-001 reports — was closed via an explicit publication-layer erratum, per the following governing decision: **the historical GEN-001 reports (`DRA-GEN-001-POST-BLIND-EVIDENCE-REVIEW.md`, `DRA-GEN-001-PHASE-2-BLIND-EXECUTION-REPORT.md`) were not modified.** They remain the unaltered, original contemporaneous study record, including the error exactly as it originally appeared.

### 1. Statistical erratum created

`docs/dra/DRA-GEN-001-STATISTICAL-ERRATUM.md` records, for all five affected locations across the two historical reports: the exact original statement, the corrected value (≤4.0% at n=75, vs. the original ≤3.0%), the calculation (3/75 = 0.04), why the original was wrong (a copy-forward of the correct n=100 rule-of-three figure, 3/100 = 0.03, applied without recalculation to the n=75 quantities), and an explicit finding that the correction changes **no** GEN-001 decision, verdict, exclusion, evaluator result, proof receipt, or digest — it is a confidence-interval labelling correction only, and if anything makes the reported bound more conservative (wider), not less. It also confirms the n=100 (≤3.0%) and n=25 (≤12%) rule-of-three figures remain correct, that no study denominator changes, and that GEN-001 and VAL-002 remain separate, non-pooled studies.

### 2. Evidence identity preserved

The erratum document explicitly states it is a later, interpretive, publication-layer correction, not a revision of the historical record; it does not regenerate, recompute, or alter any digest. Verified: `git diff`/`git status` show zero changes to either historical GEN-001 report.

### 3. Publication-facing documentation updated

Inspected all five named documents. Added a concise erratum pointer to three of them where the affected statistic is cited or the residuals/known-limitations context is discussed: `DRA-PUB-003-REPORT.md` (quantitative-results bullet), `DRA-RELEASE-README.md` (GEN-001 evidence-pointer bullet), `DRA-REPRODUCIBILITY.md` (§10 known-residuals section). Added one row to `DRA-PUBLIC-RELEASE-MANIFEST.md` classifying the three new artefacts (erratum, this audit report, the manuscript freeze receipt) as `INCLUDE`. **`DRA-PUB-003-MANUSCRIPT.md` was deliberately left unmodified for this step** — it already states the corrected figure directly (from the initial audit pass) and adding a further citation to it would have changed its word count and digest away from the exact 6,315-word version this task specified must be frozen; the erratum's own §8/§9 already record that the manuscript is the correctly-stated document and point back to it. This satisfies the task's "do not clutter every document" instruction — one canonical erratum plus three targeted publication-doc pointers, not a fifth edit to the manuscript itself.

### 4. Final manuscript freeze

Created `docs/dra/DRA-PUB-MANUSCRIPT-1-FREEZE-RECEIPT.md`, freezing the exact corrected, post-audit manuscript: path, final title, word count (6,315 — independently re-verified via `wc -w`, unchanged from the initial audit pass since no further manuscript edit was made), SHA-256 digest (`5aa6cf64b3e985dca5178db6aeb1487a8103782105d968ed62625457eb8e4f8e`, independently recomputed and matching), freeze date (2026-08-12), repository commit, a claim-register reference (`DRA-PUBLIC-CLAIMS.md` at its last-modified commit), a statistical-erratum reference, an explicit statement that no frozen scientific/evaluator artefact was modified, and publication status (`Frozen publication candidate`). Used identifier `DRA-PUB-MANUSCRIPT-1` as instructed; no existing repository convention conflicts with it (the closest precedent, `DRA-GC-1-FREEZE-RECEIPT.md`, uses a disjoint `DRA-GC-*` namespace for the evaluator, not the manuscript).

### 5. Final verification

- Independently recomputed the manuscript's SHA-256 digest and word count: both match the freeze receipt exactly.
- Re-ran the GC-1/GEN-001/VAL-002 freeze-integrity and evidence-synthesis identity-check suite: 9 files, 218 tests, all passing (unchanged from the initial audit pass).
- Confirmed via `git diff`/`git status` that both historical GEN-001 reports are byte-for-byte unchanged.
- Confirmed via `git status --short` / `git diff --stat` across the whole repository that this final-remediation step touched only publication-layer documentation: 4 pre-existing files modified (`DRA-PUB-003-REPORT.md`, `DRA-RELEASE-README.md`, `DRA-REPRODUCIBILITY.md`, `DRA-PUBLIC-RELEASE-MANIFEST.md`, each a small, targeted addition) and 2 new files created (the erratum, the freeze receipt) beyond this report itself — no evaluator, corpus, governance, GC-1, GEN-001, ENG-026, GC2-REV-001, or VAL-002 artefact was touched.
- Re-ran the publication claim-boundary audit (Issue 9's method) against every newly added or edited sentence in the four updated publication docs and the two new artefacts: no prohibited phrase (`independently validated`, `production system`, `trust infrastructure`, `guarantee`, `fully robust`, `no undiscovered [failure modes]`, etc.) was introduced in an unqualified form; the two literal string hits found are pre-existing, already-compliant occurrences (one inside the already-reviewed "rejected title candidates" framing, one inside an already-reviewed negated/qualified prohibited-phrase-list sentence describing the audit method itself).

## Verdict

**MANUSCRIPT_SCIENTIFICALLY_READY**

All ten mandatory issues from the initial audit were investigated and resolved or confirmed compliant, and the one item left open at that stage — the historical rule-of-three arithmetic error — has now been closed through a publication-layer erratum that corrects the citable record without altering the original historical evidence artefacts, exactly as the governing decision required. The manuscript is frozen at its corrected, audited state (`DRA-PUB-MANUSCRIPT-1`, SHA-256 `5aa6cf64b3e985dca5178db6aeb1487a8103782105d968ed62625457eb8e4f8e`, 6,315 words) as the publication candidate. No frozen scientific or evaluator artefact was modified at any point across either the initial audit or this final remediation.
